1. OP21 COVID-19 morbidity/mortality and vaccination against SARS-CoV-2 in patients with Inflammatory Bowel Disease in Poland: Nationwide Data. (30th January 2023) Authors: Kucha, P; Walkiewicz, D; Wieszczy, P; Reguła, J; Zagórowicz, E Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P421 Real-world effectiveness and safety of vedolizumab induction therapy for Crohn's disease in Poland – a prospective, observational POLONEZ II study considering patients reported outcomes. (30th January 2023) Authors: Liebert, A; Kłopocka, M; Cichoż-Lach, H; Michalak, A; Talar-Wojnarowska, R; Domżał-Magrowska, D; Filipiuk, A; Krogulecki, M; Kopertowska-Majchrzak, M; Eder, P; Stawczyk-Eder, K; Waszak, K; Zagórowicz, E; Wojciechowski, K; Drygała, S Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i550 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P672 Biologic therapy for Inflammatory Bowel Disease in Poland in 2020: nationwide data. (21st January 2022) Authors: Kucha, P; Zagórowicz, E; Walkiewicz, D; Perwieniec, J; Maluchnik, M; Wieszczy, P; Reguła, J Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i578 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗